News from the PANGEA study at Dana-Farber Cancer Institute: Which Smoldering Myeloma (SMM) Patients Are More Likely to Progress? Inside the PANGEA-SMM Model.

The PANGEA Model is a tool that helps patients predict their personal risk of developing myeloma within the next 1 to 10 years (The Pangea Model - SMM Risk Calculator). The model incorporates both patients' most recent lab results and their lab history from the past two years to provide a more individualized risk estimate. The PANGEA model is available to anyone who wants to use it on the website.

Read the Nature Medicine paper describing the model here.

Learn how the PANGEA model was developed in this article by one of its creators here.